Verano (OTCMKTS:VRNOF – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability.
Insider & Institutional Ownership
9.0% of Verano shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 9.1% of Verano shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Verano and Intelligent Bio Solutions, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Verano | 1 | 0 | 0 | 1 | 2.50 |
| Intelligent Bio Solutions | 1 | 1 | 0 | 0 | 1.50 |
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Verano | -41.68% | -9.54% | -4.51% |
| Intelligent Bio Solutions | -294.88% | -175.35% | -91.25% |
Earnings and Valuation
This table compares Verano and Intelligent Bio Solutions”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Verano | $878.59 million | 0.52 | -$341.86 million | ($0.98) | -1.29 |
| Intelligent Bio Solutions | $4.22 million | 1.52 | -$12.43 million | ($9.02) | -0.21 |
Intelligent Bio Solutions has lower revenue, but higher earnings than Verano. Verano is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Verano has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.25, suggesting that its share price is 325% more volatile than the S&P 500.
Summary
Verano beats Intelligent Bio Solutions on 8 of the 13 factors compared between the two stocks.
About Verano
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Receive News & Ratings for Verano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verano and related companies with MarketBeat.com's FREE daily email newsletter.
